Literature DB >> 18534484

The use of a tripolar articulation in revision total hip arthroplasty: a minimum of 24 months' follow-up.

Brett R Levine1, Craig J Della Valle, Carl A Deirmengian, Kristoffer M Breien, Steven H Weeden, Scott M Sporer, Wayne G Paprosky.   

Abstract

A retrospective cohort study of 31 hips revised with a tripolar articular construct was performed. Patient demographics and preoperative and postoperative information were recorded. Indications for a tripolar construct were recurrent dislocation and the inability to attain intraoperative stability during hip revision. Nine patients (29%) were revised to the tripolar construct after failure of a constrained liner. Twenty patients (65%) had at least one episode of instability before the most recent revision. At a mean follow-up of 38 months, modified Postel scores improved from a mean of 5.28 to 9.64 (P < .01). Radiographic follow-up revealed no evidence of component loosening/migration, osteolysis, or polyethylene wear. Two patients (7%) required further revision surgery for recurrent instability. A tripolar construct was effective in eliminating or preventing instability in 93% of the complex cases treated. These early results support the use of a tripolar construct in treating recurrent instability or instability encountered at the time of revision hip arthroplasty.

Entities:  

Mesh:

Year:  2008        PMID: 18534484     DOI: 10.1016/j.arth.2007.09.022

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  11 in total

1.  Dual mobility cups for preventing early hip arthroplasty dislocation in patients at risk: experience in a county hospital.

Authors:  Sebastian S Mukka; Sarwar S Mahmood; Göran O Sjödén; Arkan S Sayed-Noor
Journal:  Orthop Rev (Pavia)       Date:  2013-06-11

2.  Are abductor muscle quality and previous revision surgery predictors of constrained liner failure in hip arthroplasty?

Authors:  Michael G Zywiel; Loi'y H Mustafa; Peter M Bonutti; Michael A Mont
Journal:  Int Orthop       Date:  2010-02-20       Impact factor: 3.075

3.  Instability after total hip arthroplasty.

Authors:  Brian C Werner; Thomas E Brown
Journal:  World J Orthop       Date:  2012-08-18

4.  A dual-mobility cup reduces risk of dislocation in isolated acetabular revisions.

Authors:  Roberto Civinini; Christian Carulli; Fabrizio Matassi; Lorenzo Nistri; Massimo Innocenti
Journal:  Clin Orthop Relat Res       Date:  2012-06-15       Impact factor: 4.176

5.  Relevance of a press-fit dual mobility cup to deal with recurrent dislocation of conventional total hip arthroplasty: a 29-case series.

Authors:  D Saragaglia; S Ruatti; R Refaie
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-05-06

6.  The focally constrained liner is a reasonable option for revision of unstable total hip arthroplasty.

Authors:  Tatu J Mäkinen; Simcha G Fichman; Wael A Rahman; Tomas Amenabar; Oleg Safir; Allan E Gross; Paul R T Kuzyk
Journal:  Int Orthop       Date:  2015-12-23       Impact factor: 3.075

7.  Recurrence of dislocation following total hip arthroplasty revision using dual mobility cups was rare in 180 hips followed over 7 years.

Authors:  Patrice Mertl; Antoine Combes; Frédérique Leiber-Wackenheim; Michel Henri Fessy; Julien Girard; Henri Migaud
Journal:  HSS J       Date:  2012-09-19

Review 8.  The unstable total hip arthroplasty.

Authors:  Gösta Ullmark
Journal:  EFORT Open Rev       Date:  2017-03-13

9.  Dual-mobility cups for revision due to instability are associated with a low rate of re-revisions due to dislocation: 228 patients from the Swedish Hip Arthroplasty Register.

Authors:  Nils P Hailer; Rüdiger J Weiss; André Stark; Johan Kärrholm
Journal:  Acta Orthop       Date:  2012-11-01       Impact factor: 3.717

10.  LUMiC® Endoprosthetic Reconstruction After Periacetabular Tumor Resection: Short-term Results.

Authors:  Michaël P A Bus; Andrzej Szafranski; Simen Sellevold; Tomasz Goryn; Paul C Jutte; Jos A M Bramer; M Fiocco; Arne Streitbürger; Daniel Kotrych; Michiel A J van de Sande; P D Sander Dijkstra
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.